Dull March Growth For Indian Market But Some Strong Runs
This article was originally published in Scrip
The Indian pharmaceutical market reported its lowest growth in FY16 during the month of March, disrupted to some extent by regulatory and price-related actions. However, a clutch of domestic and foreign firms outpaced the market sharply.
Register for our free email digests: